Akciju sabiedriba Grindeks

Akciju sabiedriba Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of original products, generics, and active pharmaceutical ingredients in Latvia. It operates in two segments, Final Dosage Forms and Active Pharmaceutical Ingredients. The company offers heart and cardiovascular drugs, CNS drugs, and anti-cancer medication therapeutic groups under the Mildronate and Ftorafur names; and Oxytocin, a hormone that is used as a medication to facilitate childbirth. Its final dosage forms portfolio includes solid form products, as well as injections, ointments, and syrups. The company also offers contract manufacturing services of tablets, capsules, ointments, and syrups. It also exports its products to 87 countries, which primarily include the European Union countries, Russia and other CIS countries, the United States, Canada, Japan, and Vietnam. Akciju sabiedriba Grindeks was founded in 1946 and is headquartered in Riga, Latvia.